title: Effect of lazaroid U-74389G on pulmonary ischemia-reperfusion injury in dogs.
abstract: Lipid peroxidation induced by oxygen free radicals is a contributing factor in ischemia-reperfusion injury. Lazaroid U-74389G (LAZ-G) is a group of new synthetic 21-aminosteroids and inhibits irondependent lipid peroxidation. We investigated the effects of LAZ-G on pulmonary ischemia-reperfusion injury in dogs. Twenty dogs were divided into three groups. In the LAZ-G group (n = 6), LAZ-G was administered 15 min before ischemia. In the St group (n = 5), methylprednisolone was injected 15 min before ischemia and 15 min before reperfusion. In the control group (n = 9), the vehicle of Lazaroid was injected 15 min before ischemia. Warm ischemia was induced for 3 h by clamping the pulmonary artery and veins. Arterial oxygen saturation (SaO2), cardiac output (CO), left pulmonary vascular resistance (L-PVR), and blood levels of interleukin-1beta mRNA were measured. The lung specimen was harvested for histologic study and polymorphonuclear neutrophils (PMNs) counting. SaO2 levels at 30 min and 2 h after reperfusion were significantly higher in the LAZ-G group than in the control group. After 30 min of reperfusion, CO was significantly better in the LAZ-G group than in the St and control groups, and the L-PVR level was significantly lower in the LAZ-G group than in the control group. Survival rates were significantly better in the LAZ-G group than in the control group. Histological damages and PMNs infiltration were more severe in the control group than in the LAZ-G group. Interleukin-1beta mRNA levels were lower in the LAZ-G group than in the control group. Lazaroid U-74389G appears to generate a protective effect against ischemia-reperfusion injury of the lung.
authors.affiliation: Second Department of Surgery, Gunma University School of Medicine, Maebashi, Japan. takeyosi@showa.gunma-u.ac.jp
authors.forename: I
authors.initials: I
authors.lastname: Takeyoshi
authors.forename: K
authors.initials: K
authors.lastname: Iwanami
authors.forename: N
authors.initials: N
authors.lastname: Kamoshita
authors.forename: T
authors.initials: T
authors.lastname: Takahashi
authors.forename: J
authors.initials: J
authors.lastname: Kobayashi
authors.forename: N
authors.initials: N
authors.lastname: Tomizawa
authors.forename: Y
authors.initials: Y
authors.lastname: Kawashima
authors.forename: K
authors.initials: K
authors.lastname: Matsumoto
authors.forename: Y
authors.initials: Y
authors.lastname: Morishita
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D002302:Cardiac Output; D004195:Disease Models, Animal; D004285:Dogs; D007375:Interleukin-1 / Q000235:genetics; D015227:Lipid Peroxidation / Q000187:drug effects; D010100:Oxygen / Q000097:blood; D011281:Pregnatrienes / Q000494:pharmacology*; D011650:Pulmonary Alveoli / Q000473:pathology; D011652:Pulmonary Circulation; D012333:RNA, Messenger / Q000032:analysis; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D015996:Survival Rate; D014655:Vascular Resistance
chemical_list: D000975:Antioxidants; D007375:Interleukin-1; D011281:Pregnatrienes; D012333:RNA, Messenger; C074965:U 74389F; D010100:Oxygen